During the year, the Schizophrenia Network organises meetings for its members (also at the annual ECNP Congress).

Research projects
  • OPTiMiSE (Optimization of Treatment and Management of Schizophrenia in Europe)
    (European Community's Seventh Framework Programme under grant agreement No. HEALTH-F2-2010-242114)
  • EULAST (European Long-acting Antipsychotics in Schizophrenia Trial)
  • ENSANeS (ECNP Network on Schizophrenia study on Assessment of Negative Symptoms)
  • EUFEST (The European First Episode Schizophrenia Trial): Comparison of outcome in first episode schizophrenia with different low dose antipsychotic drug regimens
Recommended publications

Journal and link to the article
Mucci et al. 2019 A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale. European Neuropsychopharmacology
Kahn et al.  2018
Amisulpride and olanzapine followed by open-label treatment with clozapine in first-episode schizophrenia and schizophreniform disorder (OPTiMiSE): a three-phase switching study. Lancet Psychiatry
Volavka et al. 2016
Hostility in schizophrenia: an integrated analysis of the combined Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) and the European First Episode Schizophrenia Trial (EUFEST) studies. European Psychiatry
Landolt et al. 2016 Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST). Schizophrenia Bulletin
Leucht et al. 2015 The optimization of treatment and management of schizophrenia in Europe. (OPTiMiSE) trial: rationale for its methodology and a review of the effectiveness of switching antipsychotics. Schizophrenia Bulletin
Dazzan et al. 2015 Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research Schizophrenia Bulletin
Arango et al.  2015
Going beyond "trial-and-error" in psychiatric treatments: OPTiMiSE-ing the treatment of first episode of schizophrenia Schizophrenia Bulletin
Czobor et al. 2015 Treatment adherence in schizophrenia: A patient-level meta-analysis of combined CATIE and EUFEST studies. European Neuropsychopharmacology
Pijnenborg et al.  2015 Differential effects of antipsychotic drugs on insight in first episode schizophrenia: Data from the European First-Episode Schizophrenia Trial (EUFEST)  European Neuropsychopharmacology
Rybakowski et al. 2014 Extrapyramidal symptoms during treatment of first schizophrenia episode: results from EUFEST. European Neuropsychopharmacology
Reis Marques et al.  2014 How antipsychotics impact the different dimensions of Schizophrenia: A test of competing hypotheses. European Neuropsychopharmacology 
Wobrock et al.  2013 Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study. Schizophrenia Research
Riecher-Rossler et al. 2013 Hyperprolactinemia in antipsychotic naïve patients with first episode psychosis – results from EUFEST. Psychological Medicine 
Czobor et al. 2013 Insight and hostility as predictors and correlates of non-adherence in the European First Episode Schizophrenia Trial (EUFEST).  Journal of Clinical Psychopharmacology 
Fleischhacker et al. 2013 Metabolic Risk Factors in First Episode Schizophrenia: Prevalence and Course Analyzed from the European First Episode Schizophrenia Trial (EUFEST). International Journal of Neuropsychopharmacology
Galderisi et al. 2013 Persistent negative symptoms in first episode patients with schizophrenia: Results from the European First Episode Schizophrenia Trial. European Neuropsychopharmacology
Rybakowski et al. 2012
Treatment of depression in first episode of schizophrenia: Results from EUFEST. European Neuropsychopharmacology 
Dollfus et al.  2012
Familial sinistrality and handedness in patients with first episode schizophrenia: The EUFEST study.  Laterality 
Fleischhacker et al.  2012
Interpreting treatment trials in schizophrenia patients: Lessons learned from EUFEST. Schizophrenia Research 
Landolt et al. 2012
The interrelation of needs and quality of life in first-episode schizophrenia. European Archives of Psychiatry and Clinical Neuroscience
Landolt et al. 2012
Unmet needs in patients with first-episode schizophrenia: a longitudinal perspective.  Psychological Medicine
Volavka et al. 2011 Efficacy of antipsychotic drugs against hostility in the European First Episode Schizophrenia Trial (EUFEST).  Journal of Clinical Psychiatry
Malik et al. 2011 Sexual dysfunction in first-episode schizophrenia patients: results from European first episode schizophrenia trial. Journal of Clinical Psychopharmacology
Derks et al.  2010
Should patients be switched to a different antipsychotic drug after 2, 4 or 6 week of non response?  Journal of Clinical Psychopharmacology
Boter et al.  2010
Generalizability of the results of efficacy trials in first episode schizophrenia: comparisons between subgroups of participants of the European First Episode Schizophrenia Trial (EUFEST) Journal of Clinical Psychiatry 
Gaebel et al. 2010
Drug attitude as predictor for effectiveness in first-episode schizophrenia: results of an open randomized trial (EUFEST). European Neuropsychopharmacology
Boter et al. 2009 Effectiveness of antipsychotics in first-episode schizophrenia and schizophreniform disorder in response and remission: an open randomized clinical trial (EUFEST).  Schizophrenia Research 
Galderisi et al. 2009
Correlates of cognitive impairment in first episode schizophrenia. The EUFEST study.  Schizophrenia Research 
Davidson et al.  2009 Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open label clinical trial (EUFEST). American Journal of Psychiatry
Kahn et al.   2008 Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial. The Lancet
Fleischhacker et al.  2005
The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial. Schizophrenia Research 

Targeted Network Meetings